Lecturer in Medicine-Cardiology, Northwestern University Medical School
Pediatrics
Dr. Mary J. Malloy, MD
|
|
Give Review
Mary Malloy practices Pediatrics. She graduated from University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. She has 1 awards "CMS Meaningful Use Stage 1 Certification". Mary J. Malloy is also published. She has 97 publications published. The lastest publication: "The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds.' She accepts Medicare.
Publications
- Congenital absence of apolipoprotein e and neurological function-reply.
- Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function.
- Emerging roles of qualitative properties of lipoproteins in atherosclerosis.
- Aberrant Hetero-Disulfide Bond Formation by the Hypertriglyceridemia-Associated p.Gly185Cys APOA5 Variant (rs2075291).
- Impact of a 4q25 Genetic Variant in Atrial Flutter and the Risk of Atrial Fibrillation after Cavotricuspid Isthmus Ablation.
- Needed: a better understanding of the antiatherogenic properties of HDL.
- Evidence that an HMGA1 Gene Variant Associates with Type 2 Diabetes, Body Mass Index, and High-Density Lipoprotein Cholesterol in a Hispanic-American Population.
- Hyperlipidemia and cardiovascular disease.
- Prebeta-1 HDL and coronary heart disease.
- Polymorphisms and Noncardioembolic Stroke in Three Case-Control Studies.
- Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease.
- Mechanisms of statin-induced myalgia assessed by physiogenomic associations.
- Functional variants of the HMGA1 gene and type 2 diabetes mellitus.
- Effect of niacin on preβ-1 high-density lipoprotein levels in diabetes.
- Association between Regulator of G Protein Signaling 9-2 and Body Weight.
- Genetic variants of the ENPP1/PC-1 gene are associated with hypertriglyceridemia in male subjects.
- GOSR2 Lys67Arg is associated with hypertension in whites.
- Galanin preproprotein is associated with elevated plasma triglycerides.
- Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia.
- WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels.
- An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients.
- Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study.
- Analysis of 17,576 potentially functional SNPs in three case-control studies of myocardial infarction.
- Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia.
- Five common gene variants identify elevated genetic risk for coronary heart disease.
- A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease.
- Gene variants of VAMP8 and HNRPUL1 are associated with early-onset myocardial infarction.
- Identification of four gene variants associated with myocardial infarction.
- Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study).
- Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL.
- Variations in human HM74 (GPR109B) and HM74A (GPR109A) niacin receptors.
- Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus.
- Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults.
- Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial.
- Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids.
- Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype.
- Human renin gene BglI dimorphism associated with hypertension in two independent populations.
- Treatment of hypercholesterolemia.
- Renin gene MboI dimorphism is a discriminator for hypertension in hyperlipidaemic subjects.
- Haplotypes of the human renin gene associated with essential hypertension and stroke.
- NcoI dimorphic site located 8kb 3'' to the human apolipoprotein AIV (APOA4) gene.
- TaqI and XbaI RFLPs detected with a human apo IV (Apo4) cDNA probe.
- Hypolipidemia.
- Editorial: Early prevention of atherosclerosis.
- Bsm I RFLP at the human apolipoprotein AI-CIII gene complex locus.
- Human apolipoprotein CI (ApoC1) gene locus: BglI dimorphic site.
- Human apolipoprotein CI (apoC1) gene locus: DraI dimorphic site.
- Niacin--the long and the short of it.
- DraI RFLP in the human apolipoprotein AI-CIII-AIV gene complex.
- Influence of cholestyramine resin administration on single dose sulindac pharmacokinetics.
- Effect of cholestyramine resin on single dose valproate pharmacokinetics.
- Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia.
- Single variants can explain the association between coronary heart disease and haplotypes in the apolipoprotein(a) locus.
- Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study.
- Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia.
- The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion.
- Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders.
- Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects.
- Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.
- Molecular cloning and characteristics of a new apolipoprotein C-II mutant identified in three unrelated individuals with hypercholesterolemia and hypertriglyceridemia.
- A novel apolipoprotein C-III variant, apoC-III(Gln38-->Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin.
- Prebeta-1 HDL in plasma of normolipidemic individuals: influences of plasma lipoproteins, age, and gender.
- Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of a...
- Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene.
- Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia.
- Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man.
- Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy.
- Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia.
- Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decr...
- The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds.
- Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.
- Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
- Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of ...
- Measurement of prebeta-1 HDL in human plasma by an ultrafiltration-isotope dilution technique.
- Exploratory data analysis of hyperlipidemia on the Macintosh: software tools for analysis of biochemical, clinical, and genetic variables in 1677 consecutive lipid cli...
- Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: corre...
- Aggressive medical therapy for the prevention and treatment of coronary artery disease.
- Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.
- Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
- A multilocus genotyping assay for candidate markers of cardiovascular disease risk.
- A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci.
- Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.
- A variant primary structure of apolipoprotein C-II in individuals of African descent.
- A multilocus genotyping assay for cardiovascular disease.
- Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women.
- Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans.
- A risk factor for atherosclerosis: triglyceride-rich lipoproteins.
- When to treat hyperlipidemia.
- Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein.
- Treatment of hyperlipidemia.
- Familial hypercholesterolemia in children: treatment with p-aminosalicylic acid.
- Medical management of hyperlipidemic states.
- Association of endothelial lipase Thr111Ile polymorphism with lipid metabolism and microvascular complications in type 2 diabetic patients.
- Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia.
- Elevated baseline triglyceride levels modulate effects of HMGCoA reductase inhibitors on plasma lipoproteins.
- Drs malloy and kane respond.
Schools
University Of California San Francisco School Of Medicine
Moffitt Hospital University Of Ca
University Wa Med Center
Doctors Specialties
- Pediatrics
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCSF -
University of Washington -
University of California San Francisco School of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
San Francisco VA Medical Center -
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Julia K. Getzelman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bethany K. Hodges, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles J. Wibbelsman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexandra K. Abrams, MD |
|
|
Dr. Dale G. Sickles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jon-Michael A. Castelli, MD |
|
|
Dr. Joanna C. Ruthenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David K. Becker, MD |
|
|
Dr. Enrique Escalante, MD |
|
|
Dr. Lisa G. Dana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wen-Hsin Shen, MD |
|
|
Dr. Shelley Wu, MD
This Doctor is OpenDoctor Recommended.
|